“PTCH”-ing It Together: A Basal Cell Nevus Syndrome Review

By Lam Charlene   Ou Jason C.   Billingsley Elizabeth M.  

Dermatologic Surgery, Vol. 39, Iss. 11, 2013-11 ,pp. : 1557-1572

Elsevier

Access to resources Recommend Favorite

Comment on Basal Cell Carcinoma Rebound After Cessation of Vismodegib in an Individual With Basal Cell Nevus Syndrome

By Ally Mina S.   Wysong Ashley   Tang Jean Y.   Aasi Sumaira  

Dermatologic Surgery, Vol. 39, Iss. 9, 2013-09 ,pp. : 1413-1414

Elsevier

Access to resources Recommend Favorite

Improving physician-patient communication important

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 251, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Basal Cell Carcinoma Rebound After Cessation of Vismodegib in a Nevoid Basal Cell Carcinoma Syndrome Patient

By Wolfe Christopher M.   Green W. Harris   Cognetta Armand B.   Hatfield H. Keith  

Dermatologic Surgery, Vol. 38, Iss. 11, 2012-11 ,pp. : 1863-1866

Elsevier

Access to resources Recommend Favorite

Basal Cell Carcinoma, Syringocystadenoma Papilliferum, Trichilemmoma, and Sebaceoma Arising Within a Nevus Sebaceus Associated with Pigmented Nevi

By Wang Yan   Bu Wen-Bo   Chen Hao   Zhang Meng-Li   Zeng Xue-Si   Zhao Liang   Fang Fang  

Dermatologic Surgery, Vol. 37, Iss. 12, 2011-12 ,pp. : 1806-1810

Elsevier

Access to resources Recommend Favorite